Analysis of the EGFR gene to identify NSCLC patients who may be eligible for TKI therapies. This assay detects mutations in the EGFR gene that confer TKI sensitivity and TKI resistance.

Submit a formalin-fixed, paraffin-embedded (FFPE) tissue block

FFPE tissue block

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

• Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
• All information requested is required in order for your request to be completed

Ambient

• Samples fixed by other means, such as B+, will not be accepted.
• Decalcified bone specimens will not be accepted as this process degrades DNA.
• Improper label (unlabeled or mislabeled)
• Wrong container (anticoagulant or solution)
• Delay in transport
• Improper storage
• Inappropriate timing of collection
• Interfering substances
• Slides broken beyond repair

Cobas EGFR Mutation Test v2 (IVD, Roche)

An interpretive report will be provided

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

• Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
• All information requested is required in order for your request to be completed

Molecular Medicare billing request